Stuart Therapeutics Overview

  • Year Founded
  • 2018

Year Founded

  • Status
  • Private

  • Employees
  • 11

Employees

  • Latest Deal Type
  • Accelerator/​Inc

  • Investors
  • 6

Stuart Therapeutics General Information

Description

Developer of a synthesized peptide therapeutic platform intended to repair disease-damaged helical collagen in the eye. The company's method of action results in accelerated healing of epithelial cells, restoration of nerve function, and reduction of inflammation in various ophthalmic diseases, and offers a way to address indications such as dry eye disease, dry age-related macular degeneration, and glaucoma, enabling physicians to repair the damaged collagen and reduce inflammation.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 411 Southeast Osceola Street
  • Suite 203
  • Stuart, FL 34994
  • United States
+1 (772)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • 411 Southeast Osceola Street
  • Suite 203
  • Stuart, FL 34994
  • United States
+1 (772)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Stuart Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Accelerator/Incubator Completed Clinical Trials - Phase 3
2. Early Stage VC 09-Mar-2022 Completed Clinical Trials - Phase 3
1. Early Stage VC (Series A) 23-Mar-2021 $11M $11M Completed Clinical Trials - Phase 3
To view Stuart Therapeutics’s complete valuation and funding history, request access »

Stuart Therapeutics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A
To view Stuart Therapeutics’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Stuart Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a synthesized peptide therapeutic platform intended to repair disease-damaged helical collagen in the eye.
Drug Discovery
Stuart, FL
11 As of 2026

Rockville, MD
 

Tel Aviv, Israel
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Stuart Therapeutics Competitors (3)

One of Stuart Therapeutics’s 3 competitors is Regenerx, a Formerly VC-backed company based in Rockville, MD.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Regenerx Formerly VC-backed Rockville, MD
Azura Ophthalmics Venture Capital-Backed Tel Aviv, Israel
Aldeyra Therapeutics Formerly VC-backed Lexington, MA
You’re viewing 3 of 3 competitors. Get the full list »

Stuart Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Stuart Therapeutics Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds
Biobrit Venture Capital Minority
InFocus Capital Partners Venture Capital Minority
Keiretsu Forum Angel Group Minority
MiMo Capital (Miami) Venture Capital Minority
WARF Ventures Venture Capital Minority
You’re viewing 5 of 6 investors. Get the full list »

Stuart Therapeutics FAQs

  • When was Stuart Therapeutics founded?

    Stuart Therapeutics was founded in 2018.

  • Where is Stuart Therapeutics headquartered?

    Stuart Therapeutics is headquartered in Stuart, FL.

  • What is the size of Stuart Therapeutics?

    Stuart Therapeutics has 11 total employees.

  • What industry is Stuart Therapeutics in?

    Stuart Therapeutics’s primary industry is Drug Discovery.

  • Is Stuart Therapeutics a private or public company?

    Stuart Therapeutics is a Private company.

  • What is Stuart Therapeutics’s current revenue?

    The current revenue for Stuart Therapeutics is .

  • How much funding has Stuart Therapeutics raised over time?

    Stuart Therapeutics has raised $11M.

  • Who are Stuart Therapeutics’s investors?

    Biobrit, InFocus Capital Partners, Keiretsu Forum, MiMo Capital (Miami), and WARF Ventures are 5 of 6 investors who have invested in Stuart Therapeutics.

  • Who are Stuart Therapeutics’s competitors?

    Regenerx, Azura Ophthalmics, and Aldeyra Therapeutics are competitors of Stuart Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process